Back
Allegion PLC Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
37
ALLE
Allegion PLC
Last Price:
$127.75
Seasonality Move:
3.85%
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$73.40
Seasonality Move:
14.66%
Sell
37
Allegion PLC (ALLE)
is a Sell
Is Allegion PLC a Buy, Sell or Hold?
-
The current Allegion PLC [ALLE] share price is $127.72. The Score for ALLE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ALLE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $79.97. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALLE Stock Price Chart
What is Allegion PLC's stock price today?
-
The Allegion PLC share price today is $127.72The current trend is relatively stagnant and ALLE is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $79.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ALLE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 48.8 | Sell |
| Chaikin Money Flow: | -307895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.48 - 130.58) | Sell |
| Bollinger Bands (100): | (128.09 - 140.55) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.65 | Sell |
| Relative Strength Index (14 RSI): | 30.31 | Sell |
| Chaikin Money Flow: | 3301090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ALLE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.66 | Buy |
| 20-day SMA: | 127.25 | Buy |
| 50-day SMA: | 129.4 | Sell |
| 200-day SMA: | 132.81 | Sell |
| 8-day EMA: | 127.41 | Buy |
| 20-day EMA: | 127.73 | Sell |
| 50-day EMA: | 129.78 | Sell |
| 200-day EMA: | 131.52 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.24 | Sell |
| 20-day SMA: | 101.11 | Sell |
| 50-day SMA: | 110.69 | Sell |
| 200-day SMA: | 125.58 | Sell |
| 8-day EMA: | 91.61 | Sell |
| 20-day EMA: | 99.38 | Sell |
| 50-day EMA: | 107.77 | Sell |
| 200-day EMA: | 119.29 | Sell |
Allegion PLC Earnings Growth & ALLE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.36 per share, an increase this year of $0.36 per share, and an increase next year of $0.62 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Allegion PLC Technical Analysis
| Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||